Tesamorelin Prescription: How to Get One

Tesamorelin sits in an unusual spot among the peptides people search for. Unlike BPC-157, ipamorelin, or CJC-1295 — which exist in the US only as unapproved compounds or gray-market “research” vials — tesamorelin is a fully FDA-approved prescription drug. It’s sold under the brand name Egrifta WR, manufactured by Theratechnologies, and that approved status changes the entire prescribing picture. There is a clean, legitimate, pharmacy-dispensed route to get it. The catch is that the clean route is built around one specific medical condition, and most people searching “tesamorelin prescription” aren’t asking about that condition.

This page is about the prescribing mechanics: who is legally allowed to write the prescription, what a provider needs to see before they will, how telehealth fits in, and what insurance demands. If you’re looking for the broader picture of access routes and what each one costs, the how to get tesamorelin page covers that fork in more detail. Here we stay focused on the prescription itself.

Note: Everything below describes how prescribing works as of June 2026. Drug labeling, insurance criteria, and state telehealth rules all change. Treat this as orientation, not a substitute for talking to a licensed provider.

Yes, tesamorelin requires a prescription

There’s no ambiguity here. Tesamorelin is a prescription-only medication. The only FDA-approved tesamorelin product is Egrifta WR (which replaced the older Egrifta SV formulation through 2025), and it is dispensed exclusively through specialty pharmacies that fill a valid prescription from a licensed provider.

It’s worth being clear about what this rules out. The “tesamorelin” sold by online peptide vendors labeled “for research use only” is not the approved prescription drug. Those vials are not manufactured to pharmaceutical standards, are not approved for human use, and buying them to inject yourself is exactly the kind of unregulated gray-market route this site steers people away from. A real tesamorelin prescription means the FDA-approved product, filled by a real pharmacy. Tesamorelin is also not a scheduled controlled substance, which matters for telehealth — more on that below.

Who can legally prescribe it

The prescribing authority for tesamorelin is broad. Any US-licensed prescriber whose scope of practice includes prescription drugs can legally write it:

• Physicians (MD or DO) in any specialty.
• Nurse practitioners and physician assistants, in the states and under the supervisory arrangements where their prescribing authority allows it.
• Specialists — most commonly infectious-disease and HIV clinicians, since the approved indication lives in HIV care, but also endocrinologists who manage growth-hormone-axis and metabolic conditions.

In day-to-day practice, the people writing tesamorelin prescriptions are overwhelmingly HIV and infectious-disease providers. That’s not a legal requirement — it’s a reflection of where the approved use sits. A patient with HIV-associated lipodystrophy is already in regular care with an HIV clinician who can assess them, document the diagnosis, and manage the monitoring the drug requires. That existing relationship is what makes the prescription straightforward.

The legal breadth (“any licensed prescriber can write it”) and the practical reality (“almost all prescriptions come from HIV/ID providers”) are both true at once, and the gap between them is the whole story of off-label requests.

What the approved indication actually is

Tesamorelin has exactly one FDA-approved use: reducing excess visceral abdominal fat in adults living with HIV who have lipodystrophy. That’s it. It is the only medication approved in the US for that indication, and it works by acting as a growth-hormone-releasing factor analog that prompts the pituitary to release the body’s own growth hormone in its natural rhythm.

The labeling is also explicit about what it is not for: it states tesamorelin should not be used for weight management. This is the single most important thing for anyone arriving at this page hoping to get it prescribed as a fat-loss or body-recomposition drug. It is not a GLP-1 medication, it is not an obesity treatment, and a careful prescriber will not write it as one. If general weight loss is the goal, the tesamorelin for belly fat page explains why the approved-indication framing matters and why the off-label leap is shakier than it looks.

How the prescribing process works for the approved use

For a patient with HIV-associated lipodystrophy, the path is well-worn and runs through a few defined steps:

1. Clinical evaluation. The prescriber confirms the patient has HIV and documents lipodystrophy — typically the accumulation of visceral abdominal fat. Insurers want diagnosis codes (HIV and HIV-associated lipodystrophy) and supporting clinical detail, so this evaluation is also the paperwork foundation.
2. Baseline checks and contraindication screening. Because tesamorelin works on the growth-hormone axis, prescribers screen for things like pituitary disease, active malignancy, and pregnancy, and they plan to monitor IGF-1 levels during treatment. This is standard for a GHRH-analog drug and is part of why it’s a clinician-managed medication rather than something you self-source.
3. Prescription sent to a specialty pharmacy. Egrifta WR isn’t a drug you pick up at a regular retail counter. It’s a specialty medication, so the prescriber routes it to a specialty pharmacy, which then contacts the patient directly to arrange fulfilment.
4. Prior authorization. Most insurers require a prior authorization documenting the HIV and lipodystrophy diagnoses before they’ll cover it. The manufacturer runs a patient-support hub (THERA patient support) that helps with insurance verification, prior-auth paperwork, and appeals if a claim is denied.
5. Dispensing and ongoing monitoring. Once approved, the specialty pharmacy ships the medication, and the patient continues under the prescriber’s monitoring.

None of this involves you handling sourcing, reconstitution decisions, or dosing on your own — those are clinician-set and pharmacy-handled, which is the whole point of the approved route. For the actual price tags attached to all this, see the tesamorelin cost page.

Telehealth: possible, but with real caveats

This is the question a lot of people are actually asking, so it deserves a clear answer. Can you get tesamorelin prescribed over telehealth?

The starting point is favorable: tesamorelin is not a controlled substance. The strict federal rules that limit prescribing scheduled drugs (like stimulants or certain pain medications) over telehealth without an in-person visit simply don’t apply here. So there’s no blanket federal barrier to a telehealth tesamorelin prescription the way there is for some other drugs.

But “no federal barrier” is not the same as “easy to get online.” Several things still gate it:

• A legitimate provider-patient relationship. A prescriber has to actually evaluate you. For the approved indication, that means establishing or confirming the HIV and lipodystrophy diagnoses, which usually requires reviewing records, labs, and history — not something a two-minute intake form can responsibly do.
• State law. Telehealth prescribing rules vary by state, including what counts as a valid telehealth visit and whether the provider must be licensed in your state. A provider has to be licensed where the patient is located.
• Clinic policy. Many telehealth platforms simply choose not to prescribe a specialty HIV drug, because it falls outside their model and requires monitoring they aren’t set up to provide.
• The off-label problem again. Telehealth clinics that advertise “peptides” will sometimes offer tesamorelin off-label as an anti-aging or body-composition product. That’s legal at the prescriber’s discretion, but it’s cash-pay, the evidence outside the HIV indication is much thinner, and you should treat any clinic that offers it with no real evaluation as a red flag.

So the honest summary: telehealth is genuinely an option for tesamorelin in a way it isn’t for controlled drugs, but for the approved use you’ll usually be working with an HIV clinician who already knows you, and for off-label use you’ll be paying out of pocket and should scrutinize the provider carefully.

Off-label prescriptions: legal, but a different deal

US physicians are allowed to prescribe approved drugs off-label using their clinical judgment, and tesamorelin is no exception. A prescriber can legally write it for a non-HIV patient. But “legal” and “advisable” and “covered” are three separate questions, and off-label tesamorelin fails the last two:

• Coverage. Insurance almost never pays for off-label tesamorelin. The prior-authorization criteria are built tightly around the HIV-lipodystrophy diagnosis, so an off-label request means cash-pay at a specialty-drug price — and the brand product’s list price runs into the tens of thousands of dollars per year.
• Evidence. The strong clinical evidence for tesamorelin is in the HIV-lipodystrophy population. There’s some research interest in non-HIV visceral fat and liver fat, but it’s far less established, and prescribing into that gap is a judgment call, not a settled indication.
• Reputable prescriber behavior. A careful provider who does prescribe it off-label will still evaluate you properly, monitor IGF-1, and screen for contraindications. A provider who’ll ship it after a quick online form is cutting exactly the corners that make the approved route safe.

This is the same fork the how to get tesamorelin page lays out in full: the approved-indication prescription is the clean path, off-label is a legal-but-cash-and-caveats path, and gray-market vials aren’t a prescription at all.

What to watch out for

A few warning signs are worth naming plainly:

• “No prescription needed.” Any site offering tesamorelin without a prescription is selling research-only vials, not the approved drug. That’s the gray market, full stop.
• Prescriptions with no real evaluation. A legitimate tesamorelin prescription follows a clinical assessment. If a clinic will write it based on a checkbox form and a credit card, that’s the warning sign, not the convenience.
• Marketing it as a weight-loss drug. The label says it shouldn’t be used for weight management. A provider pitching it as a diet medication is ignoring its own labeling.

If you want the wider context on how prescription access works across peptides generally — including which ones can be legitimately compounded and which can’t — the how peptides get prescribed pillar walks through the whole landscape, and the are peptides legal in the US page covers the 2026 regulatory state more broadly.

The bottom line

Getting a tesamorelin prescription is genuinely simple if you have HIV-associated lipodystrophy: your HIV clinician evaluates you, sends the prescription to a specialty pharmacy, and a prior authorization usually unlocks insurance coverage. For anyone else, it’s legal for a provider to prescribe off-label, but you’ll be paying cash at a steep specialty price, working against thinner evidence, and you should be wary of any provider willing to write it without a proper evaluation. And whatever the route, the only real tesamorelin prescription is for the FDA-approved Egrifta WR product filled by a licensed pharmacy — not a vial bought online.